Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
ATRA

Updated 10/6/2026, 2:28 PM ET.

ATRA

Atara Biotherapeutics, Inc.

Buy$999,994

Cherry Brian N

Director

104,166 shat $9.60Filed Sep 4, 6:20 PM ETFiling
ATRA

Atara Biotherapeutics, Inc.

Sale$40,883

Nguyen AnhCo

President and CEO, Director

5,062 shat $8.08Filed Aug 26, 7:45 PM ETFiling

Read from public SEC filings. Not financial advice.